Paper41557129
METTL5 promotes tumor progression and ferroptosis resistance via MGST1 in HCC.
Ji T and 7 others. Mol Cell Biochem, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. METTL5 promotes tumor progression and ferroptosis resistance via MGST1 in HCC. Papers, record 41557129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41557129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Ferroptosis | Major topic |
| Methyltransferases | Major topic |
| Neoplasm Proteins | Major topic |
| Humans | |
| Animals | |
| Male | |
| Mice | |
| Female | |
| Cell Line, Tumor | |
| Disease Progression | |
| Cell Proliferation | |
| Mice, Nude | |
| Glutathione Transferase |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2320001006760 | Self funded science and technology plan project of Foshan | PubMed | ||
| B2024180 | Guangdong Medical Research Fund | PubMed | ||
| 82372851 | National Natural Science Foundation of China | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 41989692 | Correction: METTL5 promotes tumor progression and ferroptosis resistance via MGST1 in HCC. | https://conductscience.org/library/papers/41989692 |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36800991 | N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis. | Cell Chem Biol | 2023 | https://conductscience.org/library/papers/36800991 | PubMed |
| 2 | 37648102 | Microsomal glutathione transferase 1 controls metastasis and therapeutic response in melanoma. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/37648102 | PubMed |
| 3 | 33357433 | Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth. | Cell Rep | 2020 | https://conductscience.org/library/papers/33357433 | PubMed |
| 4 | 21633660 | Role of MGST1 in reactive intermediate-induced injury. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/21633660 | PubMed |
| 5 | 33539732 | MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells. | Cell Chem Biol | 2021 | https://conductscience.org/library/papers/33539732 | PubMed |
| 6 | 36602428 | METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. | Cancer Commun (Lond) | 2023 | https://conductscience.org/library/papers/36602428 | PubMed |
| 7 | 35022030 | The role of m6A RNA methylation in cancer metabolism. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35022030 | PubMed |
| 8 | 33495651 | Ferroptosis: mechanisms, biology and role in disease. | Nat Rev Mol Cell Biol | 2021 | https://conductscience.org/library/papers/33495651 | PubMed |
| 9 | 33268902 | Ferroptosis: molecular mechanisms and health implications. | Cell Res | 2021 | https://conductscience.org/library/papers/33268902 | PubMed |
| 10 | 34171541 | MiR-379-5p targets microsomal glutathione transferase 1 (MGST1) to regulate human glioma in cell proliferation, migration and invasion and epithelial-mesenchymal transition (EMT). | Biochem Biophys Res Commun | 2021 | https://conductscience.org/library/papers/34171541 | PubMed |
| 11 | 32300195 | Role of RNA modifications in cancer. | Nat Rev Cancer | 2020 | https://conductscience.org/library/papers/32300195 | PubMed |
| 12 | 40103455 | Upregulation of miR-3130-5p Enhances Hepatocellular Carcinoma Growth by Suppressing Ferredoxin 1 : miR-3130-5p Enhances HCC Growth via Inhibiting FDX1. | Curr Mol Pharmacol | 2024 | https://conductscience.org/library/papers/40103455 | PubMed |
| 13 | 39375506 | NSUN2 regulates Wnt signaling pathway depending on the m5C RNA modification to promote the progression of hepatocellular carcinoma. | Oncogene | 2024 | https://conductscience.org/library/papers/39375506 | PubMed |
| 14 | 10673221 | Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG). A widespread protein superfamily. | Am J Respir Crit Care Med | 2000 | https://conductscience.org/library/papers/10673221 | PubMed |
| 15 | 35999469 | N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. | Nat Metab | 2022 | https://conductscience.org/library/papers/35999469 | PubMed |
| 16 | 29702404 | MGST1, a GSH transferase/peroxidase essential for development and hematopoietic stem cell differentiation. | Redox Biol | 2018 | https://conductscience.org/library/papers/29702404 | PubMed |
| 17 | 15641772 | Microsomal glutathione S-transferase 1 in the retinal pigment epithelium: protection against oxidative stress and a potential role in aging. | Biochemistry | 2005 | https://conductscience.org/library/papers/15641772 | PubMed |
| 18 | 28450942 | Immunohistochemical analysis of microsomal glutathione S-transferase 1 and clusterin expression in lens epithelial cells of patients with pseudoexfoliation syndrome. | Exp Ther Med | 2017 | https://conductscience.org/library/papers/28450942 | PubMed |
| 19 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 20 | 38114887 | RNA m6A modifications regulate crosstalk between tumor metabolism and immunity. | Wiley Interdiscip Rev RNA | 2024 | https://conductscience.org/library/papers/38114887 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953691 | METTL family proteins: functional heterogeneity, tumor regulatory networks, immune microenvironment remodeling and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42953691 | PubMed |
| 42511695 | GSH-Related Enzymes GPx4, Chac1, and GSTs and Redox Regulation of Ferroptosis in Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511695 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| METTL5 | 29081 | PubTator's text mining | https://conductscience.org/library/genes/29081 | NCBI Gene |
| MGST1 | 4257 | PubTator's text mining | https://conductscience.org/library/genes/4257 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41557129
GET https://conductscience.org/api/papers/v1/41557129/references?page=2